Introduction to Biological and Psychobiological Aspects of PCOS

  • John A. BarryEmail author


Polycystic ovary syndrome (PCOS) is a complex medical condition in which psychology and biology interact in ways that we are only beginning to appreciate. Understanding the psychological aspects can therefore be a challenging task, and this book aims to map out the full landscape of these issues. To help readers, the first chapter offers a whistle-stop tour of some of the main features of PCOS. Apart from the key medical features (testosterone and insulin), the elephant in the room of PCOS today is the fact that it not only incompletely understood, but experts in this field yet come to a consensus on how it should be defined. Some readers might want to skip ahead to chapters that are focused more purely on psychology, but for the brave, read on.


Diagnosis of PCOS Phenotype Theories of PCOS Testosterone Insulin 


  1. Abbott, D. H., Eisner, J. R., Goodfriend, T., Medley, R. D., Peterson, E. J., Colman, R. J., … Dumesic, D. A. (2002, June 19–22). Leptin and total free fatty acids are elevated in the circulation of prenatally androgenized female rhesus monkeys. Abstract P2–329. 84th Annual Meeting of The Endocrine Society, San Francisco, CA.Google Scholar
  2. Acién, P., Quereda, F., Matallı́n, P., Villarroya, E., López-Fernández, J. A., Acién, M., … Alfayate, R. (1999). Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: A heterogeneous group of disorders. Fertility and Sterility, 72(1), 32–40.PubMedCrossRefPubMedCentralGoogle Scholar
  3. Agrawal, R., Sharma, S., Bekir, J., Conway, G., Bailey, J., Balen, A. H., & Prelevic, G. (2004). Prevalence of polycystic ovaries and polycystic ovary syndrome in lesbian women compared with heterosexual women. Fertility and Sterility, 82, 1352–1357.PubMedCrossRefPubMedCentralGoogle Scholar
  4. Anderson, S. A., Barry, J. A., & Hardiman, P. J. (2014). Risk of coronary heart disease and risk of stroke in women with polycystic ovary syndrome: A systematic review and meta-analysis. International Journal of Cardiology, 176(2), 486–487.PubMedCrossRefPubMedCentralGoogle Scholar
  5. Astapova, O., Minor, B. M., & Hammes, S. R. (2019). Physiological and pathological androgen actions in the ovary. Endocrinology, 160(5), 1166–1174.PubMedCrossRefPubMedCentralGoogle Scholar
  6. Azziz, R. (2006). Controversy in clinical endocrinology: Diagnosis of polycystic ovarian syndrome: The Rotterdam criteria are premature. The Journal of Clinical Endocrinology and Metabolism, 9, 781–785.CrossRefGoogle Scholar
  7. Azziz, R. (2014). Polycystic ovary syndrome: What’s in a name? The Journal of Clinical Endocrinology and Metabolism, 99(4), 1142–1145.PubMedPubMedCentralCrossRefGoogle Scholar
  8. Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., … Androgen Excess Society. (2006). Position statement: Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline. The Journal of Clinical Endocrinology and Metabolism, 91, 4237–4245. Scholar
  9. Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., … (Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society). (2008). The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: The complete task force report. Fertility and Sterility, 91, 456–488.PubMedCrossRefPubMedCentralGoogle Scholar
  10. Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., … Witchel, S. F. (2009). The androgen excess and PCOS society criteria for the polycystic ovary syndrome: The complete task force report. Fertility and Sterility, 91(2), 456–488.PubMedCrossRefPubMedCentralGoogle Scholar
  11. Azziz, R., Marin, C., Hoq, L., Badamgarav, E., & Song, P. (2005). Health care-related economic burden of the polycystic ovary syndrome during the reproductive life span. The Journal of Clinical Endocrinology & Metabolism, 90(8), 4650–4658.CrossRefGoogle Scholar
  12. Barclay, L., & Murata, P. (2006, October). Obese premenopausal women are at high risk for PCOS. Medscape Today. Retrieved October 16, 2008, from
  13. Barker, D. J. (2004). The developmental origins of chronic adult disease. Acta Paediatrica Supplement, 93, 26–33.CrossRefGoogle Scholar
  14. Barrett, E. S., Hoeger, K. M., Sathyanarayana, S., Abbott, D. H., Redmon, J. B., Nguyen, R. H. N., & Swan, S. H. (2018). Anogenital distance in newborn daughters of women with polycystic ovary syndrome indicates fetal testosterone exposure. Journal of Developmental Origins of Health and Disease, 9(3), 307–314.PubMedPubMedCentralCrossRefGoogle Scholar
  15. Barry, J. A., Kay, A. R., Navaratnarajah, R., Iqbal, S., Bamfo, J. E. A. K., David, A. L., … Hardiman, P. J. (2010). Umbilical vein testosterone in female infants born to mothers with polycystic ovary syndrome is elevated to male levels. Journal of Obstetrics and Gynaecology, 30(5), 444–446.PubMedCrossRefPubMedCentralGoogle Scholar
  16. Barry, J. A., Hardiman, P. J., Saxby, B. K., & Kuczmierczyk, A. (2011). Testosterone and mood dysfunction in women with polycystic ovarian syndrome compared to subfertile controls. Journal of Psychosomatic Obstetrics and Gynecology, 32(2), 104–111.PubMedCrossRefPubMedCentralGoogle Scholar
  17. Barry, J. A., Azizia, M. M., & Hardiman, P. J. (2014). Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: A systematic review and meta-analysis. Human Reproduction Update, 20(5), 748–758.PubMedPubMedCentralCrossRefGoogle Scholar
  18. Barry, J. A., & Owens, R. (2019). From fetuses to boys to men: The impact of testosterone on male lifespan development. In The Palgrave handbook of male psychology and mental health (pp. 3–24). Cham: Palgrave Macmillan.CrossRefGoogle Scholar
  19. Beach, F. A. (1975). Hormonal modification of sexually dimorphic behavior. Psychoneuroendocrinology, 1, 3–23.CrossRefGoogle Scholar
  20. Berenbaum, S. A., & Hines, M. (1992). Early androgens are related to childhood sex-typed toy preferences. Psychological Science, 3, 203–206.CrossRefGoogle Scholar
  21. Buffington, C. K., Givens, J. R., & Kitabchi, A. E. (1991). Opposing actions of dehydroepiandrosterone and testosterone on insulin sensitivity. In vivo and in vitro studies of hyperandrogenic females. Diabetes, 40, 693–700.PubMedCrossRefPubMedCentralGoogle Scholar
  22. Burger, H. G. (2002). Androgen production in women. Fertility and Sterility, 77, S3–S5.PubMedCrossRefGoogle Scholar
  23. Busby, M., & Simpson, L. (2019, April). Perceptions of coping with the long-term consequences of polycystic ovary syndrome at different stages of the menopausal transition. Poster session presented at the meeting of the British Psychological Society NI Branch 2019 Annual Conference, Belfast, NI.
  24. Cesta, C. E., Månsson, M., Palm, C., Lichtenstein, P., Iliadou, A. N., & Landén, M. (2016). Polycystic ovary syndrome and psychiatric disorders: Co-morbidity and heritability in a nationwide Swedish cohort. Psychoneuroendocrinology, 73, 196–203.PubMedCrossRefPubMedCentralGoogle Scholar
  25. Dapas, M., Sisk, R., Legro, R. S., Urbanek, M., Dunaif, A., & Hayes, M. G. (2019). Family-based quantitative trait meta-analysis implicates rare noncoding variants in DENND1A in polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism, 104(9), 3835–3850.CrossRefGoogle Scholar
  26. Day, F., Karaderi, T., Jones, M. R., Meun, C., He, C., Drong, A., … Magi, R. (2018). Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria. PLoS Genetics, 14(12), e1007813.PubMedPubMedCentralCrossRefGoogle Scholar
  27. De Sutter, P., Dutré, T. I. N. E. K. E., Meerschaut, F. V., Stuyver, I., Van Maele, G. E. O. R. G. E. S., & Dhont, M. (2008). PCOS in lesbian and heterosexual women treated with artificial donor insemination. Reproductive Biomedicine Online, 17(3), 398–402.PubMedCrossRefPubMedCentralGoogle Scholar
  28. Dhurandhar, N. V., Kulkarni, P. R., Ajinkya, S. M., Sherikar, A. A., & Atkinson, R. L. (1997). Association of adenovirus infection with human obesity. Obesity Research, 5, 464–469.PubMedCrossRefPubMedCentralGoogle Scholar
  29. Dhurandhar, N. V., Whigham, L. D., Abbott, D. H., Schultz-Darken, N. J., Israel, B. A., Bradley, S. M., … Atkinson, R. L. (2002). Human adenovirus Ad-36 promotes weight gain in male rhesus and marmoset monkeys. The Journal of Nutrition, 132, 3155–3160.PubMedCrossRefPubMedCentralGoogle Scholar
  30. Diamanti-Kandarakis, E., Kandarakis, H., & Legro, R. S. (2006). The role of genes and environment in the etiology of PCOS. Endocrine, 30, 19–26.PubMedCrossRefPubMedCentralGoogle Scholar
  31. Diamanti-Kandarakis, E., Christakou, C., Palioura, E., Kandaraki, E., & Livadas, S. (2008). Does polycystic ovary syndrome start in childhood? Pediatric Endocrinology Reviews, 5, 904–911.PubMedPubMedCentralGoogle Scholar
  32. Ding, T., Hardiman, P. J., Petersen, I., & Baio, G. (2018). Incidence and prevalence of diabetes and cost of illness analysis of polycystic ovary syndrome: A Bayesian modelling study. Human Reproduction, 33(7), 1299–1306.PubMedCrossRefPubMedCentralGoogle Scholar
  33. Dumesic, D. A., Abbott, D. H., & Padmanabhan, V. (2007). Polycystic ovary syndrome and its developmental origins. Reviews in Endocrine & Metabolic Disorders, 8(2), 127–141.CrossRefGoogle Scholar
  34. Dunaif, A., & Fauser, B. C. (2013). Renaming PCOS—A two-state solution. The Journal of Clinical Endocrinology & Metabolism, 98(11), 4325–4328.CrossRefGoogle Scholar
  35. Dunaif, A., & Thomas, A. (2001). Current concepts in the polycystic ovary syndrome. Annual Review of Medicine, 52, 401–419.PubMedCrossRefPubMedCentralGoogle Scholar
  36. Dunaif, A., Segal, K. R., Futterweit, W., & Dobrjansky, A. (1989). Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes, 38, 1165–1174.PubMedCrossRefPubMedCentralGoogle Scholar
  37. Dunlap, J. L., Gerall, A. A., & Carlton, S. F. (1978). Evaluation of prenatal androgen and ovarian secretions on receptivity in female and male rats. Journal of Comparative and Physiological Psychology, 92, 280–288.PubMedCrossRefPubMedCentralGoogle Scholar
  38. Dusková, M., & Stárka, L. (2006). The existence of a male equivalent of the polycystic ovary syndrome—The present state of the issue. Prague Medical Report, 107, 17–25.PubMedPubMedCentralGoogle Scholar
  39. Eggers, S., & Kirchengast, S. (2001). The polycystic ovary syndrome—A medical condition but also an important psychosocial problem. Collegium Antropologicum, 25, 673–685.PubMedPubMedCentralGoogle Scholar
  40. Eggers, S., Hashimoto, D. M., & Kirchengast, S. (2007). An evolutionary approach to explain the high frequency of the polycystic ovary syndrome (PCOS). Anthropologischer Anzeiger, 65, 169–179.CrossRefGoogle Scholar
  41. Elsenbruch, S., Hahn, S., Kowalsky, D., Offner, A. H., Schedlowski, M., Mann, K., & Janssen, O. E. (2003). Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. The Journal of Clinical Endocrinology and Metabolism, 88, 5801–5807.PubMedCrossRefPubMedCentralGoogle Scholar
  42. Escobar-Morreale, H. F. (2018). Polycystic ovary syndrome: Definition, aetiology, diagnosis and treatment. Nature Reviews. Endocrinology, 14(5), 270–284.PubMedCrossRefPubMedCentralGoogle Scholar
  43. Escobar-Morreale, H. F., Luque-Ramírez, M., & San Millán, J. L. (2005). The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocrine Reviews, 26, 251–282.PubMedCrossRefPubMedCentralGoogle Scholar
  44. Farrell, K., & Antoni, M. H. (2010). Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: Biobehavioral mechanisms and interventions. Fertility and Sterility, 94(5), 1565–1574.PubMedPubMedCentralCrossRefGoogle Scholar
  45. Filippou, P., & Homburg, R. (2017). Is foetal hyperexposure to androgens a cause of PCOS? Human Reproduction Update, 23(4), 421–432.PubMedCrossRefPubMedCentralGoogle Scholar
  46. Forest, M. G., Bétuel, H., Couillin, P., & Boué, A. (1981). Prenatal diagnosis of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency by steroid analysis in the amniotic fluid of mid-pregnancy: Comparison with HLA typing in 17 pregnancies at risk for CAH. Prenatal Diagnosis, 1, 197–207.PubMedCrossRefPubMedCentralGoogle Scholar
  47. Franceschi, R., Gaudino, R., Marcolongo, A., Chiara Gallo, M., Rossi, L., Antoniazzi, F., & Tatò, L. (2009). Prevalence of polycystic ovary syndrome in young women who had idiopathic central precocious puberty. Fertility and Sterility, 93(4), 1185–1191. In Press, Corrected Proof, Available online 9 January 2009.PubMedCrossRefPubMedCentralGoogle Scholar
  48. Franks, S. (2008). Polycystic ovary syndrome in adolescents. International Journal of Obesity, 32, 1035–1041.PubMedCrossRefPubMedCentralGoogle Scholar
  49. Franks, S., Mccarthy, M. I., & Hardy, K. (2006). Development of polycystic ovary syndrome: Involvement of genetic and environmental factors. International Journal of Andrology, 29(1), 278–285.PubMedCrossRefGoogle Scholar
  50. Gallinelli, A., Matteo, M. L., Volpe, A., & Facchinetti, F. (2000). Autonomic and neuroendocrine responses to stress in patients with functional hypothalamic secondary amenorrhea. Fertility and Sterility, 73, 812–816.PubMedCrossRefGoogle Scholar
  51. Gelis, J. (1989). The secret of birth. Histoire des Sciences Médicales, 23, 109–114.PubMedGoogle Scholar
  52. Genton, P., Bauer, J., Duncan, S., Taylor, A. E., Balen, A. H., Eberle, A., … Sauer, M. V. (2001). On the association between valproate and polycystic ovary syndrome. Epilepsia, 42, 295–304.PubMedCrossRefGoogle Scholar
  53. Gersh, F., & Parella, A. (2018). PCOS SOS. A gynecologist’s lifeline to naturally restore your rhythms, hormones, and happiness. Irvine: Integrative Medical Group.Google Scholar
  54. Glueck, C. J., Goldenberg, N., Wang, P., Loftspring, M., & Sherman, A. (2004). Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: Prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. Human Reproduction, 19, 510–521.PubMedCrossRefGoogle Scholar
  55. Gore, A. C., Chappell, V. A., Fenton, S. E., Flaws, J. A., Nadal, A., Prins, G. S., … Zoeller, R. T. (2015). EDC-2: The endocrine society’s second scientific statement on endocrine-disrupting chemicals. Endocrine Reviews, 36(6), E1–E150.PubMedPubMedCentralCrossRefGoogle Scholar
  56. Gougeon, A. (1996). Regulation of ovarian follicular development in primates: Facts and hypotheses. Endocrine Reviews, 17(2), 121–155.PubMedCrossRefPubMedCentralGoogle Scholar
  57. Goy, R. W., & McEwen, B. S. (1980). Sexual differentiation of the brain. Cambridge, MA: MIT Press.Google Scholar
  58. Goyal, M., & Dawood, A. S. (2017). Debates regarding lean patients with polycystic ovary syndrome: A narrative review. Journal of Human Reproductive Sciences, 10(3), 154.PubMedPubMedCentralCrossRefGoogle Scholar
  59. Hamilton, W. G. (1963). The evolution of altruistic behavior. American Naturalist, 97, 354–356.CrossRefGoogle Scholar
  60. Hamilton, W. G. (1964a). The genetical evolution of social behavior. I. Journal of Theoretical Biology, 7, 1–16.PubMedCrossRefPubMedCentralGoogle Scholar
  61. Hamilton, W. G. (1964b). The genetical evolution of social behaviour. II. Journal of Theoretical Biology, 7, 17–27.PubMedCrossRefGoogle Scholar
  62. Harris, J. A., Vernon, P. A., & Boomsma, D. I. (1998). The heritability of testosterone: A study of Dutch adolescent twins and their parents. Behavior Genetics, 28, 165–171.PubMedCrossRefGoogle Scholar
  63. Hawkes, K., O’Connell, J. F., Jones, N. G., Alvarez, H., & Charnov, E. L. (1998). Grandmothering, menopause, and the evolution of human life histories. Proceedings of the National Academy of Sciences, 95, 1336–1339.CrossRefGoogle Scholar
  64. Hines, M. (2002). Sexual differentiation of human brain and behaviour. In D. Pfaff, A. P. Arnold, A. M. Etgen, S. E. Fahrbach, & R. T. Rubin (Eds.), Hormones, brain and behavior (Vol. 4, pp. 425–462). New York: Academic Press.CrossRefGoogle Scholar
  65. Hines, M. (2009). Gonadal hormones and sexual differentiation of human brain and behavior. In P. D. W. Hormones (Ed.), Brain and Behavior (2nd ed., pp. 1869–1909). New York: Academic Press.Google Scholar
  66. Hines, M., & Kaufman, F. R. (1994). Androgen and the development of human sex-typical behavior: Rough-and-tumble play and sex of preferred playmates in children with congenital adrenal hyperplasia (CAH). Child Development, 65(4), 1042–1053.PubMedCrossRefGoogle Scholar
  67. Hines, M., Brook, C., & Conway, G. S. (2004). Androgen and psychosexual development: Core gender identity, sexual orientation and recalled childhood gender role behavior in women and men with congenital adrenal hyperplasia (CAH). Journal of Sex Research, 41, 1–7.CrossRefGoogle Scholar
  68. Hines, M., Fane, B. A., Pasterski, V. L., Mathews, G. A., Conway, G. S., & Brook, C. (2003). Spatial abilities following prenatal androgen abnormality: Targeting and mental rotations performance in individuals with congenital adrenal hyperplasia. Psychoneuroendocrinology, 28(8), 1010–1026.PubMedCrossRefPubMedCentralGoogle Scholar
  69. Homburg, R., & Crawford, G. (2014). The role of AMH in anovulation associated with PCOS: A hypothesis. Human Reproduction, 29, 1117–1121.PubMedCrossRefGoogle Scholar
  70. Hong, Y., Gagnon, J., Rice, T., Pérusse, L., Leon, A. S., Skinner, J. S., … Rao, D. C. (2001). Familial resemblance for free androgens and androgen glucuronides in sedentary black and white individuals: The HERITAGE Family Study. Health, Risk Factors, Exercise Training and Genetics. The Journal of Endocrinology, 70, 485–492.CrossRefGoogle Scholar
  71. Hrdy, S. B. (1999). Mother nature. Berlin: Verlag.Google Scholar
  72. Hu, S., Leonard, A., Seifalian, A., & Hardiman, P. (2007). Vascular dysfunction during pregnancy in women with polycystic ovary syndrome. Human Reproduction, 22, 1532–1539.PubMedCrossRefPubMedCentralGoogle Scholar
  73. Hunter, M. H., & Sterrett, J. J. (2000). Polycystic ovary syndrome: It’s not just infertility. American Family Physician, 62, 1079–1088.PubMedPubMedCentralGoogle Scholar
  74. Ingudomnukul, E., Baron-Cohen, S., Wheelwright, S., & Knickmeyer, R. (2007). Elevated rates of testosterone-related disorders in women with autism spectrum conditions. Hormones and Behavior, 51, 597–604.PubMedCrossRefPubMedCentralGoogle Scholar
  75. Iniguez, G., Ong, K., Bazaes, R., Avila, A., Salazar, T., Dunger, D., & Mericq, V. (2006). Longitudinal changes in insulin-like growth factor-I, insulin sensitivity, and secretion from birth to age three years in small-for-gestational-age children. The Journal of Clinical Endocrinology & Metabolism, 91(11), 4645–4649.CrossRefGoogle Scholar
  76. Isojärvi, J. I., Rättyä, J., Myllylä, V. V., Knip, M., Koivunen, R., Pakarinen, A. J., … Tapanainen, J. S. (1998). Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Annals of Neurology, 43(4), 446–451.PubMedCrossRefGoogle Scholar
  77. Jahanfar, S., Maleki, H., Mosavi, A. R., & Jahanfar, M. (2004). Leptin and its association with polycystic ovary syndrome: A twin study. Gynecological Endocrinology, 18, 327–334.PubMedCrossRefPubMedCentralGoogle Scholar
  78. Kahsar-Miller, M. D., Nixon, C., Boots, L. R., Go, R. C., & Azziz, R. (2001). Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertility and Sterility, 75, 53–58.PubMedCrossRefGoogle Scholar
  79. Kandaraki, E., Chatzigeorgiou, A., Livadas, S., Palioura, E., Economou, F., Koutsilieris, M., … Diamanti-Kandarakis, E. (2011). Endocrine disruptors and polycystic ovary syndrome (PCOS): Elevated serum levels of bisphenol A in women with PCOS. The Journal of Clinical Endocrinology & Metabolism, 96(3), E480–E484.CrossRefGoogle Scholar
  80. Keski-Rahkonen, A., Bulik, C. M., Pietiläinen, K. H., Rose, R. J., Kaprio, J., & Rissanen, A. (2007). Eating styles, overweight and obesity in young adult twins. European Journal of Clinical Nutrition, 61, 822–829.PubMedCrossRefGoogle Scholar
  81. Kissebah, A. H., Vydelingum, N., Murray, R., Evans, D. J., Hartz, A. J., Kalkhoff, R. K., & Adams, P. W. (1982). Relation of body fat distribution to metabolic complications of obesity. Clinics in Endocrinology and Metabolism, 54, 254–260.CrossRefGoogle Scholar
  82. Kitzinger, C., & Willmott, J. (2002). ‘The thief of womanhood’: Women’s experience of polycystic ovarian syndrome. Social Science & Medicine, 54, 349–361.CrossRefGoogle Scholar
  83. Kondoh, Y., Uemura, T., Ishikawa, M., Yokoi, N., & Hirahara, F. (1999). Classification of polycystic ovary syndrome into three types according to response to human corticotropin-releasing hormone. Fertility and Sterility, 72, 15–20.PubMedCrossRefPubMedCentralGoogle Scholar
  84. Lambertini, L., Saul, S. R., Copperman, A. B., Hammerstad, S. S., Yi, Z., Zhang, W., … Kase, N. (2017). Intrauterine reprogramming of the polycystic ovary syndrome: Evidence from a pilot study of cord blood global methylation analysis. Frontiers in Endocrinology, 8, 352.PubMedPubMedCentralCrossRefGoogle Scholar
  85. Lazurova, Z., Figurova, J., Hubkova, B., & Lazurova, I. (2018, May). Relationship of urinary bisphenol A to metabolic and hormonal profile in PCOS women. In 20th European Congress of Endocrinology (Vol. 56). Bristol: BioScientifica.Google Scholar
  86. Legro, R. S., Driscoll, D., Strauss, J. F., Fox, J., & Dunaif, A. (1998). Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proceedings of the National Academy of Sciences, 95(25), 14956–14960.CrossRefGoogle Scholar
  87. Leveroni, C. L., & Berenbaum, S. A. (1998). Early androgen effects on interest in infants: Evidence from children with congenital adrenal hyperplasia. Developmental Neuropsychology, 14, 321–340.CrossRefGoogle Scholar
  88. Li, T. T., Xu, L. Z., Chen, Y. H., Deng, H. M., Liang, C. Y., Liu, Y., … Han, D. W. (2011). Effects of eight environmental endocrine disruptors on insulin resistance in patients with polycystic ovary syndrome: A preliminary investigation. Nan fang yi ke da xue xue bao= Journal of Southern Medical University, 31(10), 1753–1756.PubMedPubMedCentralGoogle Scholar
  89. Manikkam, M., Crespi, E. J., Doop, D. D., Herkimer, C., Lee, J. S., Yu, S., … Padmanabhan, V. (2004). Fetal programming: Prenatal testosterone excess leads to fetal growth retardation and postnatal catch-up growth in sheep. Endocrinology, 145, 790–798.PubMedCrossRefPubMedCentralGoogle Scholar
  90. Manlove, H. A., Guillermo, C., & Gray, P. B. (2008). Do women with polycystic ovary syndrome (PCOS) report differences in sex-typed behavior as children and adolescents?: Results of a pilot study. Annals of Human Biology, 35, 584–595.PubMedCrossRefPubMedCentralGoogle Scholar
  91. Marshall, K. (2001). Polycystic ovary syndrome: Clinical considerations. Alternative Medicine Review, 6, 272–292.PubMedPubMedCentralGoogle Scholar
  92. Mathews, G. A., Fane, B. A., Conway, G. S., Brook, C. G., & Hines, M. (2009). Personality and congenital adrenal hyperplasia: Possible effects of prenatal androgen exposure. Hormones and Behavior, 55, 285–291.PubMedCrossRefPubMedCentralGoogle Scholar
  93. McCarthy, M. M. (2008). Estradiol and the developing brain. Physiological Reviews, 88, 91–134.PubMedPubMedCentralCrossRefGoogle Scholar
  94. McKenna, T. J., & Cunningham, S. K. (1995). Adrenal androgen production in polycystic ovary syndrome. European Journal of Endocrinology, 133, 383–389.PubMedCrossRefPubMedCentralGoogle Scholar
  95. Miazgowski, T., Martopullo, I., Widecka, J., Miazgowski, B., & Brodowska, A. (2019). National and regional trends in the prevalence of polycystic ovary syndrome since 1990 within Europe: The modeled estimates from the Global Burden of Disease Study 2016. Archives of Medical Science, 15(1).
  96. Miller, W. L., & Levine, L. S. (1987). Molecular and clinical advances in congenital adrenal hyperplasia. The Journal of Pediatrics, 111, 1–17.PubMedCrossRefPubMedCentralGoogle Scholar
  97. Moran, L. J., Brinkworth, G., Noakes, M., & Norman, R. J. (2006). Effects of lifestyle modification in polycystic ovarian syndrome. Reproductive Biomedicine Online, 12, 569–578.PubMedCrossRefPubMedCentralGoogle Scholar
  98. Moran, C., Reyna, R., Boots, L. S., & Azziz, R. (2004). Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess. Fertility and Sterility, 81(1), 126–131.PubMedCrossRefGoogle Scholar
  99. Nestler, J. E. (1990). Insulin-like growth factor II is a potent inhibitor of the aromatase activity of human placental cytotrophoblasts. Endocrinology, 127, 2064–2070.PubMedCrossRefPubMedCentralGoogle Scholar
  100. Nordenstrom, A., Servin, A., Bohlin, G., Larsson, A., & Wedell, A. (2002). Sex-typed toy play behavior correlates with the degree of prenatal androgen exposure assessed by CYP21 genotype in girls with congenital adrenal hyperplasia. Journal of Clinical Endocrinology and Metabolism, 87, 5119–5124.PubMedCrossRefPubMedCentralGoogle Scholar
  101. Norman, R. J., Dewailly, D., Legro, R. S., & Hickey, T. E. (2007). Polycystic ovary syndrome. Lancet, 370, 685–697.PubMedCrossRefPubMedCentralGoogle Scholar
  102. Pasquali, R., Gambineri, A., Biscotti, D., Vicennati, V., Gagliardi, L., Colitta, D., … Morselli-Labate, A. M. (2000). Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. The Journal of Clinical Endocrinology & Metabolism, 85(8), 2767–2774.CrossRefGoogle Scholar
  103. Pasterski, V., Hindmarsh, P., Geffner, M., Brook, C., Brain, C., & Hines, M. (2007). Increased aggression and activity level in 3- to 11-year-old girls with congenital adrenal hyperplasia (CAH). Hormones and Behavior, 52, 368–374.PubMedPubMedCentralCrossRefGoogle Scholar
  104. Pellatt, L., Rice, S., & Mason, H. D. (2010). Anti-Müllerian hormone and polycystic ovary syndrome: A mountain too high? Reproduction, 139, 825–833.Google Scholar
  105. Pfaff, D., Arnold, A.P., Etgen, A.M., Fahrbach, S.E., & Rubin, R.T. (Eds.). (2002). Hormones, brain and behavior (Vol. 4, pp. 425–462). New York: Academic Press.Google Scholar
  106. Resko, J. A., Buhl, A. E., & Phoenix, C. H. (1987). Treatment of pregnant rhesus macaques with testosterone propionate: Observations on its fate in the fetus. Biology of Reproduction, 37, 1185–1191.PubMedCrossRefPubMedCentralGoogle Scholar
  107. Resko, J. A., & Ellinwood, W. E. (1984). Sexual differentiation of testosterone he brain of primates. In M. Serio, M. Motta, M. Zanisi, & L. Martini (Eds.), Sexual differentiation: Basic and clinical aspects (pp. 169–181). New York: Raven Press.Google Scholar
  108. Roselli, C. E., Stadelman, H., Reeve, R., Bishop, C. V., & Stormshak, F. (2007). The ovine sexually dimorphic nucleus of the medial preoptic area is organized prenatally by testosterone. Endocrinology, 148, 4450–4457.PubMedCrossRefPubMedCentralGoogle Scholar
  109. Rosner, W. (1991). Plasma steroid binding proteins. Endocrinology and Metabolism Clinics of North America, 20, 697–720.PubMedCrossRefPubMedCentralGoogle Scholar
  110. Sam, S. (2007). Obesity and polycystic ovary syndrome. Obesity Management, 3, 69–73.PubMedPubMedCentralCrossRefGoogle Scholar
  111. Sam, S., Coviello, A. D., Sung, Y. A., Legro, R. S., & Dunaif, A. (2008). Metabolic phenotype in the brothers of women with polycystic ovary syndrome. Diabetes Care, 31(6), 1237–1241.PubMedPubMedCentralCrossRefGoogle Scholar
  112. Schattmann, L., & Sherwin, B. B. (2007). Testosterone levels and cognitive functioning in women with polycystic ovary syndrome and in healthy young women. Hormones and Behavior, 51, 587–596.PubMedCrossRefGoogle Scholar
  113. Schenker, J. G. (2000). Women’s reproductive health: Monotheistic religious perspectives. International Journal of Gynaecology and Obstetrics, 70, 77–86.PubMedCrossRefPubMedCentralGoogle Scholar
  114. Shaw, L. M., & Elton, S. (2008). Polycystic ovary syndrome: A transgenerational evolutionary adaptation. BJOG, 115, 144–148.PubMedCrossRefPubMedCentralGoogle Scholar
  115. Slijper, F. M. (1984). Androgens and gender role behaviour in girls with congenital adrenal hyperplasia (CAH). In Progress in brain research (Vol. 61, pp. 417–422). Amsterdam: Elsevier.Google Scholar
  116. Smail, P. J., Reyes, F. I., Winter, J. S. D., & Faiman, C. (1981). The fetal hormonal environment and its effect on the morphogenesis of the genital system. In S. J. Kogan & E. S. E. Hafez (Eds.), Pediatric andrology (pp. 9–19). The Hague: Martinus Nijhoff.CrossRefGoogle Scholar
  117. Stanley, T., & Misra, M. (2008). Polycystic ovary syndrome in obese adolescents. Current Opinion in Endocrinology, Diabetes, and Obesity, 15, 30–36.PubMedCrossRefPubMedCentralGoogle Scholar
  118. Sultan, C., & Paris, F. (2008). Clinical expression of polycystic ovary syndrome in adolescent girls. Fertility and Sterility, 86(Suppl 1), S6.Google Scholar
  119. Szydlarska, D., Machaj, M., & Jakimiuk, A. (2017). History of discovery of polycystic ovary syndrome. Advances in Clinical and Experimental Medicine, 26(3), 555–558.CrossRefGoogle Scholar
  120. Tata, B., Mimouni, N. E. H., Barbotin, A. L., Malone, S. A., Loyens, A., Pigny, P., … Dal Bello, F. (2018). Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood. Nature Medicine, 24(6), 834.PubMedPubMedCentralCrossRefGoogle Scholar
  121. The Rotterdam ESHRE/ASRM—Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod, 19, 41–47.Google Scholar
  122. Tsilchorozidou, T., Overton, C., & Conway, G. S. (2004). The pathophysiology of polycystic ovary syndrome. Clinical Endocrinology, 60(1), 1–17.PubMedCrossRefPubMedCentralGoogle Scholar
  123. Udry, J. R., Morris, N. M., & Kovenock, J. (1995). Androgen effects on women’s gendered behaviour. Journal of Biosocial Science, 27(3), 359–368.PubMedCrossRefGoogle Scholar
  124. Vanky, E., Salvesen, K. A., Heimstad, R., Fougner, K. J., Romundstad, P., & Carlsen, S. M. (2004). Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: Results of a randomized study. Human Reproduction, 19, 1734–1740.PubMedCrossRefPubMedCentralGoogle Scholar
  125. Vink, J. M., Sadrzadeh, S., Lambalk, C. B., & Boomsma, D. I. (2006). Heritability of polycystic ovary syndrome in a Dutch twin-family study. The Journal of Clinical Endocrinology and Metabolism, 91, 2100–2104.PubMedCrossRefGoogle Scholar
  126. Williamson, K., Gunn, A. J., Johnson, N., & Milsom, S. R. (2001). The impact of ethnicity on the presentation of polycystic ovarian syndrome. Australian and New Zealand Journal of Obstetrics and Gynaecology, 41(2), 202–206.PubMedCrossRefGoogle Scholar
  127. Wilson, J. D., George, F. W., & Griffin, J. E. (1981). The hormonal control of sexual development. Science, 211, 1278–1284.PubMedCrossRefPubMedCentralGoogle Scholar
  128. Xita, I., Georgiou, L., Lazaros, V., Psofaki, G. K., & Tsatsoulis, A. (2008). The synergistic effect of sex hormone-binding globulin and aromatase genes on polycystic ovary syndrome phenotype. European Journal of Endocrinology, 158, 861–865.PubMedCrossRefPubMedCentralGoogle Scholar
  129. Yen, S. S. C. (1991). Chronic anovulation caused by peripheral report. J. Clin. Psychiatry 61, 173–178. Endocrine disorders. In S. S. C. Yen & R. B. Jaffe (Eds.), Reproductive endocrinology: Physiology, pathophysiology and clinical management (3rd ed., pp. 576–630). Philadelphia: W.B. Saunders.Google Scholar
  130. Yilmaz, B., Vellanki, P., Ata, B., & Yildiz, B. O. (2018). Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: A systematic review and meta-analysis. Fertility and Sterility, 109(2), 356–364.PubMedPubMedCentralCrossRefGoogle Scholar
  131. Zawadski, J. K., & Dunaif, A. (1992). Diagnostic criteria for polycystic ovary syndrome; towards a rational approach. In A. Dunaif, J. R. Givens, & F. Haseltine (Eds.), Polycystic ovary syndrome (pp. 377–384). Boston: Blackwell Scientific.Google Scholar

Copyright information

© The Author(s) 2019

Authors and Affiliations

  1. 1.University College LondonLondonUK

Personalised recommendations